Roche’s Polivy combination therapy sets new standard of care for untreated aggressive lymphoma
Merck’s investigational ADC with R-CHP demonstrates 100% response rate for B-cell lymphoma
AbbVie announces emotional impact report on mental health of underrepresented CLL cancer patients
NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis
FDA RMAT status for Affimed and Artiva’s lymphoma combo therapy
Muna Therapeutics and GSK to accelerate development of novel treatments for Alzheimer’s disease
Briefs: Venus Remedies and GPT Healthcare
Eugia Pharma receives USFDA approval for Pazopanib Tablets, 200 mg
Lupin’s R&D facility in Pune bags LEED Platinum Certification
FDA accepts supplemental Biologics License Application for Roche’s Columvi combination
The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily single-pill regimen
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes